rs41273619
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006218.4(PIK3CA):c.1747-13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0481 in 1,268,272 control chromosomes in the GnomAD database, including 1,578 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.051   (  211   hom.,  cov: 32) 
 Exomes 𝑓:  0.048   (  1367   hom.  ) 
Consequence
 PIK3CA
NM_006218.4 intron
NM_006218.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.80  
Publications
7 publications found 
Genes affected
 PIK3CA  (HGNC:8975):  (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016] 
PIK3CA Gene-Disease associations (from GenCC):
- overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - megalencephaly-capillary malformation-polymicrogyria syndromeInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
 - vascular malformationInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Cowden syndrome 5Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
 - familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 - hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84). 
BP6
Variant 3-179219558-T-C is Benign according to our data. Variant chr3-179219558-T-C is described in ClinVar as Benign. ClinVar VariationId is 259959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0557  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0510  AC: 7748AN: 151960Hom.:  212  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
7748
AN: 
151960
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0469  AC: 10621AN: 226646 AF XY:  0.0470   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
10621
AN: 
226646
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0478  AC: 53307AN: 1116194Hom.:  1367  Cov.: 14 AF XY:  0.0471  AC XY: 26727AN XY: 567718 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
53307
AN: 
1116194
Hom.: 
Cov.: 
14
 AF XY: 
AC XY: 
26727
AN XY: 
567718
show subpopulations 
African (AFR) 
 AF: 
AC: 
1066
AN: 
26012
American (AMR) 
 AF: 
AC: 
1549
AN: 
39272
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1968
AN: 
22842
East Asian (EAS) 
 AF: 
AC: 
2
AN: 
37776
South Asian (SAS) 
 AF: 
AC: 
925
AN: 
75596
European-Finnish (FIN) 
 AF: 
AC: 
3191
AN: 
52380
Middle Eastern (MID) 
 AF: 
AC: 
241
AN: 
4990
European-Non Finnish (NFE) 
 AF: 
AC: 
41939
AN: 
808950
Other (OTH) 
 AF: 
AC: 
2426
AN: 
48376
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.491 
Heterozygous variant carriers
 0 
 2487 
 4974 
 7461 
 9948 
 12435 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 1250 
 2500 
 3750 
 5000 
 6250 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0510  AC: 7749AN: 152078Hom.:  211  Cov.: 32 AF XY:  0.0508  AC XY: 3774AN XY: 74354 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
7749
AN: 
152078
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
3774
AN XY: 
74354
show subpopulations 
African (AFR) 
 AF: 
AC: 
1733
AN: 
41540
American (AMR) 
 AF: 
AC: 
779
AN: 
15268
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
301
AN: 
3462
East Asian (EAS) 
 AF: 
AC: 
2
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
56
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
786
AN: 
10594
Middle Eastern (MID) 
 AF: 
AC: 
14
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
3883
AN: 
67896
Other (OTH) 
 AF: 
AC: 
145
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 368 
 736 
 1105 
 1473 
 1841 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 84 
 168 
 252 
 336 
 420 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:8 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:4 
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 06, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided    Benign:2 
Jul 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Cowden syndrome 5    Benign:1 
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cowden syndrome    Benign:1 
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.